alendronate has been researched along with Prostatic Hyperplasia in 1 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shih, WJ | 1 |
| Quan, H | 1 |
1 other study available for alendronate and Prostatic Hyperplasia
| Article | Year |
|---|---|
Planning and analysis of repeated measures at key time-points in clinical trials sponsored by pharmaceutical companies.
Topics: Alendronate; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Data Collectio | 1999 |